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Abstract
Background: Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder commonly associated with
insulin resistance (IR). Previous studies indicate about the expression of molecules involved in the insulin pathway
in endometria of women with PCOS-IR. Therefore, the aim of the present study was to evaluate the effect of
insulin and testosterone in the expression of these proteins in the endometria and immortal endometrial stromal
cell line (T-HESCs).
Methods: We examined the protein levels of Munc18c, PKC zeta, phospho-PKC Zeta, and Syntaxin-4. Protein levels
were assessed by Western Blot and/or immunohistochemistry in proliferative endometria (NPE = 6) and in PCOS
endometria with insulin resistance (PCOSE-IR = 6). We also evaluated whether high concentrations of insulin (100
nM) and/or testosterone (100 nM), during a 24 h stimulatory period, affected the expression of these proteins in an
immortal endometrial stromal cell line (T-HESCs). Once stimulated, proteins were extracted from cells and were
assessed by Western Blot analysis. Immunocytochemistry was performed to detect AR in T-HESC cells.
Results: Western Blot data showed decreased expression (p < 0,05) of Munc18c and phospho-PKC Zeta in PCOS-IR
endometria (PCOSE-IR) with respect to the control (NPE). In the in vitro study, Western Blot analysis showed
decreased levels of Munc18c, PKC Zeta and phospho-PKC Zeta with the different hormonal treatments when
compared to the control condition (no hormonal stimulation) (p < 0,05). The AR was present in the endometrial
stromal cell line (T-HESC).
Conclusion: The conditions of hyperinsulinism and hyperandrogenism present in PCOS-IR patients modulate the
expression and/or phosphorylation of the proteins involved in the insulin pathway at the endometrial level. These
data extend to the T-HESCs cells results, where insulin and testosterone exert an effect on both the expression and
phosphorylation of proteins present in the pathway.
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Background
Polycystic Ovary Syndrome (PCOS) is a common endo-
crine disease with an unknown etiology that affects
between 5 to 10% of women in reproductive age. The
principal clinical manifestations of PCOS are: oligo-
anovulation, clinical and/or biochemical hyperandrogen-
ism, and polycystic ovaries detected by ultrasonography.
PCOS is associated with defects in insulin activity, where a
high percentage of patients present symptoms of insulin
resistance (IR), often associated with hyperinsulinemia [1].
Fat and muscle tissue samples from PCOS women present
an altered content and/or activation of molecules related
to the metabolic insulin signaling pathway [2,3]. An ade-
quate expression of molecules involved in glucose uptake
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any medium, provided the original work is properly cited.is necessary for the maintenance of cellular function, not
only in normal insulin target tissues, but also in those
involved in reproduction [4].
A previous study established the presence of the insulin
receptor, PKB/Akt and the insulin dependent glucose
transporter GLUT4 in endometrial tissue, indicating the
presence of the insulin cascade [5]. Also, it has been
reported that androgen excesses influence glucose uptake
in endometrial epithelial cell cultures, which cause a
decrease in the expression of IRS-1 mRNA, IRS-1 and
GLUT4 [1]. Furthermore, reports have indicated that rat
skeletal muscle myotubes exposed to insulin and testos-
terone increase phosphorylation of Ser-636/639 residue
in IRS-1, compared to the control condition, suggesting a
link between IR and hyperandrogenism, both of which
are present in PCOS-IR women [6].
The molecular pathway that transmits the insulin sig-
nal is triggered by the binding of insulin with its receptor.
This initiates the Tyr phosphorylation of IRS-1, which in
turn activates PI3-K and induces downstream activation
of PKB/Akt and atypical PKCs, such as PKC Zeta (PKCζ)
[7]. PKCζ belongs to a Ser/Thr kinase family, and once
activated by PDK1 (Thr-410) it participates in the
upstream Ser phosphorylation of IRS-1, which lowers the
insulin signal, acting as a negative regulator [8]. Down-
stream, PKCζ participates in actin remodelling, allowing
the translocation of GLUT4 to the plasma membrane
[9,10]. Even more, reports of primary cell cultures of rat
skeletal muscle have shown that an insulin stimulus
causes PKCζ to associate directly with the GLUT4 vesi-
cle, where it phosphorylates VAMP-2 and together are
translocated to the plasma membrane [11].
The fusion of the GLUT4 vesicle with the plasma
membrane is mediated by the SNARE complex, which is
formed by VAMP2, SNAP23, and Syntaxin-4. When
Munc18c binds to Syntaxin-4, it acts as a negative regula-
tor, inhibiting the formation of the complex [12]. How-
ever, when PKCζ interacts with Munc18c, the SNARE
complex is allowed to form and the GLUT4 vesicle fuses
with the plasma membrane [9,10]. The incorporation of
GLUT4 into the cell surface is an essential component of
glucose uptake.
In our study, we employed ex vivo endometrial samples
and in vitro cultured endometrial stromal cells (T-HESCs)
to explore the effects of high androgen and/or insulin con-
centration on expression levels of certain proteins involved
in the insulin pathway.
Methods
Materials
The polyclonal antibodies anti-Munc18-c (M7695) and
anti-Syntaxin-4 (HPA001330) were purchased from
SIGMA-Aldrich (USA). The polyclonal antibodies for
PKCζ (ab59364) and PKCζ (phosphoT410) (ab75816)
were purchased from Abcam Inc. (USA). The polyclonal
AR antibody was obtained from Santa Cruz Biotechnol-
ogy, Inc. (USA). The monoclonal b-actin antibody
(A5441) was purchased from SIGMA-Aldrich (USA).
Secondary antibodies [anti-mouse and anti-rabbit immo-
nuglobin G (IgG)] were purchased from Amersham Bios-
ciences (Amersham International, Piscataway, NJ, USA).
The endometrial cell line was derived from stromal cells
(T-HESCs) obtained from an adult woman with miomas,
and was purchased from American Type Culture Collec-
tion, ATCC number: CRL-4003. Protease inhibitor cock-
tail was obtained from Roche Mol Biochemicals
(Mannheim, Germany) and bovine serum albumin (BSA)
protein assay kit from Pierce (Rockford, IL, USA); labeled
streptavidin biotin kit was purchased from Dako (CA,
USA). DMEM Ham’s F-12 medium (D2906), puromycin,
antimycotic/antibiotic, and testosterone were all obtained
from SIGMA-Aldrich (USA). Insulin-Transferrin-Sele-
nium (ITS), sterile PBS, and human recombinant insulin
were all purchased from GIBCO (USA). Fetal bovine
serum treated with dextran carbon was acquired from
HYCLONE (USA).
Subjects
Control endometria (NPE) were obtained from 6 healthy
women with proven fertility during the proliferative
phase of the menstrual cycle, at the time of hysterectomy
for benign pathologies of the uterus at the University of
Chile Clinical Hospital, School of Medicine. The PCOS-
IR endometrial samples (PCOSE) were obtained by
Pipelle suction curette from the corpus of the uteri of 6
women. The endometrial morphology of PCOS women
is comparable to the proliferative phase of control
women. This was the first time these women attended
the Infertility Clinic at the University of Chile Clinical
Hospital, School of Medicine. None of the women,
neither controls nor those with PCOS, had taken oral
contraceptives or other medications for at least 3 months
before starting the study. Glucose and insulin levels were
evaluated by an oral glucose tolerance test with a 75 g
load of glucose. In order to determine an IR condition,
we measured plasma glucose and insulin levels at 2 h
post glucose load. The diagnosis of IR was determined
when 120 min insulin levels were 2 SDS of insulin con-
centration over the mean of the control group, as in pre-
vious studies [5]. Additionally, homeostasis model
assessment (HOMA-IR) index was calculated for all
patients. Noyes criteria [13] were applied by an experi-
enced pathologist to confirm, on the basis of histological
dating, the endometrial phase of control and PCOS-IR
endometria. The diagnosis of PCOS was made according
to the Rotterdam Consensus [14] and the Androgen
Excess Society criteria [15] for the definition of PCOS.
The exclusion criteria were women who presented
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hypothyroidism (TSH >5 mIU/ml), androgen secreting
tumors (total testosterone >2 ng/ml; dehydroepiandros-
terone sulfate (DHEAS) >2600 ug/dl), Cushing’ss y n -
drome (urine cortisol concentration >50 ug/dl at 24 h
and fasting plasma concentration of cortisol >25 ug/dl),
congenital adrenal hyperplasia (17-OH progesterone >2,5
ng/ml), diabetes or treatment with hormones and/or ovu-
lation induction. The reference values are from the
World Health Organization Program (estradiol and pro-
gesterone), glycaemia values are a world consensus, basal
insulin is based in the values stated in the kit and 120
minutes insulin level post administration of glucose and
the other hormones determinations normal range values
are from the Laboratory of Endocrinology and Reproduc-
tive Biology, University of Chile Clinical Hospital, School
of Medicine. This investigation was approved by the Ethi-
cal Committees from the University of Chile Clinical
Hospital, School of Medicine and informed written con-
sent was obtained from all subjects.
Cell culture and treatments
The T-HESCs cells were cultured in growth media
(DMEM Ham’s F-12 medium, 1X Insulin-Transferrin-
Selenium (ITS), 10% fetal bovine serum treated with dex-
tran carbon, puromycin 500 ng/mL, 1X of antimycotic/
antibiotic) at 37°C in a 5% CO2 atmosphere until conflu-
ence was achieved. After achieving about 80% confluence,
cells were cultured in 10 cm Petri-dishes for 48 h at a
ratio of 800000 cells/plate in growth media without the
insulin contained in ITS, at 37°C in a 5% CO2 atmo-
sphere. The cultures with no hormonal stimulation were
used as the control for the study. Then, cells were washed
twice with sterile PBS. The cultures were further sub-
jected for 24 h to three different treatments: 1) the addi-
tion of 100 nM testosterone; 2) 100 nM of human
recombinant insulin; and 3) the addition of 100 nM tes-
tosterone and 100 nM human recombinant insulin. Once
stimulated for 24 h, the cell cultures were washed with
cold PBS; then, lysis buffer (25 mM Tris-HCl pH 7.4,
0.5 mM EGTA 25 mM NaCl, 1% Nonidet P-40, 1 mM
Na3VO4, 10 mM NaF, 1X protease inhibitors (Roche,
IN)) was added. Next, the cells were scraped and soni-
cated at 4°C and centrifuged at 1500 g for 6 min at 4°C.
The resulting supernatant was used to determine the
protein concentration with the BCA Protein Assay kit.
Immunocytochemical detection
For immunocytochemical detection, 200000 T-HESC
cells were cultured on slides for 24 h, with or without tes-
tosterone and then were permeabilized with 0.3% Triton
for 10 min at room temperature. Slides were then incu-
bated in 3% hydrogen peroxide for 15 min to prevent
endogenous peroxidase activity. Next, non-specific
binding was inhibited by incubating samples in non-fat
dehydrated milk for 10 min. The primary antibody for
AR (polyclonal, 1:150) was applied to the samples and
incubated overnight at 4°C. Negative controls were
analyzed on adjacent sections incubated without the anti-
body. The secondary antibody was an anti-rabbit IgG-
HRP diluted at 1:300. Samples were incubated for 30 min
at 37°C. The chromogen was developed by the streptavi-
din-peroxidase system and 3, 3’ diaminobenzidine was
used as the substrate, counterstaining was performed
with hematoxylin. The slides were evaluated on an Olym-
pus optical microscope (Olympus BX51TF Tokyo, Japan).
Tissue preparation
Endometrial tissue samples from the two studied groups
(NPE and PCOSE-IR) were divided into two fragments. A
fragment of each sample was fixed in 4% buffered formal-
d e h y d ef o r2 4h ,e m b e d d e di np a r a f f i na n dc u ti n5t o
6 μm thick sections before histological and immunohisto-
chemical studies. The second fragment of each sample
was first frozen in liquid nitrogen and stored at -80°C, and
then homogenized in lysis buffer (25 mM Tris-HCl pH
7.4, 0.5 mM EGTA 25 mM NaCl, 1% Nonidet P-40, 1 mM
Na3VO4, 10 mM NaF), and 1X protease inhibitor (Roche,
IN) was then added. Afterwards, samples were centrifuged
at 10000 g for 20 min at 4°C. The resulting supernatant
was used to determine the protein concentration with the
BCA Protein Assay kit.
Immunohistochemical detection
Paraffin sections of human endometrial tissue were depar-
affinized in xylene and gradually hydrated through graded
alcohols. The sections were incubated in 10 mM sodium
citrate buffer (pH 6.0) at 95°C for 30 min, incubating the
samples in 3% hydrogen peroxide for 15 min prevented
endogenous peroxidase activity. Nonspecific antibody
binding was inhibited by incubating samples with the
blocking solution (HistostainRSP, ZYMED) for 10 min.
Primary antibodies PKCζ (polyclonal; 1:100), phosphory-
lated PKCζ (polyclonal; 1:100), Munc18c (polyclonal;
1:1000) and Syntaxin-4 (polyclonal; 1:350) were applied to
the samples and incubated overnight at 4°C. The negative
controls were analyzed on adjacent sections incubated
without the respective primary antibody. The secondary
antibody used in all cases was a biotinylated anti-rabbit/
anti-mouse/anti-goat immunoglobulin. The chromogen
was developed by the streptavidin-peroxidase system and
3, 3’ diaminobenzidine was used as the substrate; counter-
staining was performed with hematoxylin. The slides were
evaluated on an Olympus optical microscope (Olympus
BX51TF Tokyo, Japan). Slide analysis was performed by
the measurement of positive pixel intensity with the use of
the semi quantitative analysis tool IOD (Integrated Optical
Density), in the Image Pro Plus 6.0 program. Equally sized
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different regions of the sample. The mean of these values
was obtained per sample and studied group.
Western blot analysis
Total protein (50 μg of endometrial tissue and 25 μgo f
cultured cells) was denatured and fractionated using 10%
1D-SDS-PAGE and transferred to a nitrocellulose mem-
brane. Membranes were blocked for 1 h in TTBS (20 mM
of Tris, pH 7.5; 137 mM of NaCl; and 0.1% Tween-20)
with 10% non-fat dehydrated milk or 10% BSA. The mem-
branes were washed twice for 5 min with TTBS and incu-
bated with antibodies against Munc18c (polyclonal 1:500),
PKCζ (polyclonal 1:1000), phospho-PKCζ (polyclonal
1:1000), and Syntaxin-4 (polyclonal 1: 500), overnight at
4°C. The membranes were then washed twice for 5 min
with TTBS and incubated for 1 h at room temperature
with anti-rabbit IgG peroxidase-linked species-specific
antibody (1: 10000). After the membranes were washed
with TTBS three times for 5 min, the bound antibodies
were detected with an enhanced chemiluminicence sys-
tem. Band intensities were quantified by scanning densito-
metry utilizing the UN-SCAN-IT software, Automated
Digitizing System, version 5.1.
Statistical evaluation
The number of subjects in this study was calculated
assuming a = 0.05 and b = 0.20 and a difference between
means of 0.25 and a standard deviation of 0.2 according to
previous studies [5]. The data were analysed using the Kol-
mogorov-Smirnov distribution test to determine if they
were parametric or not. Comparison groups were analysed
by Student’s t-test for parametric distributions, and by the
Mann Whitney test for non-parametric distributions. For
multiple comparisons, the ANOVA statistical test was
used followed by the Tukey test. For all cases, p-values <
0.05 were considered significant. Statistical tests were per-
formed using Prism for Windows, version 5.0 (Graph-Pad
Software, Inc).
Results
Clinical and endocrine characteristics
The clinical and endocrine characteristics of the two
groups of women are summarized in Table 1. The higher
mean age of the NPE (Normal Proliferative Endome-
trium) compared to PCOS women is inherent to the
design of the study, where the endometrial samples from
the control group are obtained at the time of hysterect-
omy. All PCOS women presented a BMI compatible with
the condition of moderately obesity, according to the fact
that 50-70% of PCOS women are obese, while the control
group was preferentially women bearing overweight. In
addition, all PCOS women participants of this study pre-
sented excessive ovarian androgen production, which
taking into account the decreased SHBG blood levels,
leads to a significantly higher free androgen index (FAI)
in these women. All women diagnosed as bearing PCOS
were also classified as insulin resistant by the appropriate
tests, thus grouped under PCOSE-IR (Table 2).
Immunodetection of Munc18c, PKCζ, phospho-PKCζ and
Syntaxin-4
Immunolocalization of Munc18c, PKCζ, phospho-PKCζ
and Syntaxin-4 in endometria obtained from the two
groups of women is shown in Figure 1 and Table 3. The
immunohistochemical analysis of Munc18c revealed an
increase in the protein levels of PCOSE-IR when com-
pared to NPE stromal compartment (p < 0.05). PKCζ pro-
tein detection showed that endometria from proliferative
phase presented a higher epithelial immunostaining com-
pared to the stromal compartment (p < 0.05) (Figure 1). In
PCOS-IR endometria, a decrease in the detection of the
protein in both compartments was observed when com-
pared to the control endometrium in the proliferative state
(p < 0.05). The analysis of the staining in the PCOS-IR
endometria, reveals a homogeneous distribution in both
compartments, epithelial and stromal. For the phosphory-
lated form of the protein (phospho-PKCζ), a homogeneous
Table 1 Clinical and hormonal characteristics of the
subjects
Control NPE PCOSE-IR
AGE 39.7 ± 1.2 27.2 ± 0.6*
BMI 29.7 ± 2 32.7 ± 0.9
Testosterone (ng/dL) 0.4 ± 0.1 0.8 ± 0.1*
SHBG (nmol/L) 51.7 ± 9.5 24.2 ± 2.1*
FAI 3.7 ± 0.7 13.5 ± 1.6*
Estradiol (pmol/L) 270.7 ± 22.4 228.3 ± 3.5
Progesterone (nmol/L) 2.2 ± 0.3 1.9 ± 0.1
17-OH-Progesterone (ng/mL) 1.4 ± 0.3 19 ± 0.2
Androstenedione (ng/mL) 0.6 ± 0.2 2.8 ± 0.2*
The values are expressed as mean ± SEM. *p < 0.05 NPE vs PCOSE-IR Blood
samples from women during their normal proliferative phase (NPE) and from
women with Polycystic Ovarian Syndrome and Insulin Resistance (PCOSE-IR). n
= 6 for each studied group. BMI Body Mass Index, FAI Free Androgen Index,
FP Follicular Phase, LP Luteal Phase
Table 2 Metabolic characteristics of the subjects
NPE PCOSE-IR
Basal Glycaemia (mg/dL) 66.3 ± 7.4 69.4 ± 3.0
Glycaemia 120 min (mg/dL) 73.5 ± 9.8 105.5 ± 6.0
Basal Insulin (μUI/mL) 13.6 ± 2.3 19.3 ± 3.1
Insulin 120 min (μUI/mL) 49.6 ± 5.8 116.5 ± 14.1*
HOMA-IR 2.2 ± 0.91 3.3 ± 0.6
Values are expressed as mean ± SEM. NPE = Normal Proliferative
Endometrium; PCOSE-IR = women with Polycystic Ovary Syndrome with
Insulin Resistance. HOMA-IR: fasting glycaemia × insulinemia divided by 405.
*p < 0.05 between groups
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Page 4 of 11Figure 1 Immunohistochemistry for proteins of the insulin signaling pathway. Representative image from immunohistochemical detection
of Munc18c (A), PKCζ (B), phospho-PKCζ (C) and Syntaxin-4 (D) in paraffin wax sections of proliferative endometria (n = 6) (left panel) and
PCOSE-IR (n = 6) (right panel). The hematoxylin/eosin staining showed comparable architecture in the two analyzed groups. Positive staining
was detected in epithelial and stromal cells of all studied endometria for all antigens. Magnification 400× in all panels. Inserts show negative
controls for immunohistochemical assays. Scale bars represent 50 μm.
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menstrual cycle was observed. In PCOS-IR endometria, a
decrease in the expression of the protein in both compart-
ments was noticeable, with a significant difference between
the stromal compartment of the endometrium PCOS-IR
compared to the same compartment in control endome-
trium in the proliferative state (p < 0,05).
In general, Syntaxin-4 showed more immunostaining in
the epithelial compartment compared to the stroma
(Figure 1). Moreover, when compared to NPE a significant
(p < 0.05) decrease in epithelial staining was observed in
PCOS-IR endometria, whereas, higher IOD levels were
obtained in the stromal compartment of pathological
endometria. In the PCOS-IR endometria, immunostaining
was similar between both compartments.
Expression levels of proteins in endometrial tissues
Western Blot analysis was performed for Munc18c, PKCζ,
phospho-PKCζ and Syntaxin-4. The analysis of these pro-
teins was done comparing protein expression between con-
trol and PCOS-IR endometria (Figure 2). The protein
expression of Munc18c decreased significantly, approxi-
mately 50%, in the PCOS-IR endometria compared to the
control NPE (p < 0.05). On the other hand, no variation in
the protein expression for PKCζ was observed. However,
the phosphorylation of the protein, expressed as the ratio of
phospho-PKCζ/b-actin a significant decrease (approxi-
mately 40%), with respect to the control endometria (p <
0.05).
Immunocytochemical detection of AR in T-HESCs cells
In unstimulated T-HESC cells, a weak immunostaining
was observed for AR mostly in the cytoplasm (Figure 3A).
However, when cells were stimulated with androgens, the
positive staining was observed mainly at the nuclear level
(Figure 3B). This is in agreement with previous observa-
tions for the AR in the endometrial tissue samples [16,17].
Effect of insulin and/or testosterone in T-HESC cells
An endometrial stromal cell line was used to determine
if hormone excess in cell culture affects protein
expression in the insulin pathway. In order to simulate
the PCOS-IR condition in cells, high doses of testoster-
one and insulin were added to the culture system.
Exposure of T-HESCs to 100 nM insulin and/or 100
nM testosterone significantly decreased protein expres-
sion evaluated by Western Blot of Munc18c (p < 0.05)
(Figure 4A). PKCζ protein expression was significantly
decreased when the cells were treated with 100 nM tes-
tosterone (p < 0.05). However, the other hormonal treat-
ments for PCK ζ did not reach the level of statistical
significance (Figure 4B). The phosphorylation of PKCζ
was reduced when cells were treated with the combina-
tion of 100 nM insulin and 100 nM testosterone com-
pared to the control condition (Figure 4C); whereas, all
treatments did not affect Syntaxin-4 protein expression
in cells (Figure 4D).
Discussion
Previous studies report that the synergetic effect
between the overproduction of androgens and insulin
resistance present in many PCOS women contributes to
the alteration of the function in several tissues, including
the endometrium [2,3]. In turn, excess androgen induces
changes in the expression of proteins related to tissue
homeostasis, intracellular steroid bioavailability [18-20]
and uterine receptivity [17] in PCOS endometria.
Also, it has been described that hyperinsulinemia in
PCOS could possibly be due to defects in the expression
and/or activity of proteins downstream from the insulin
receptor [21,22]. Thus, understanding protein expression
in insulin signaling in PCOS-IR patients could help
expand knowledge about reproductive failure observed
in the majority of these cases [5,23,24].
Several laboratories have established that the endome-
trium is an insulin responsive tissue, by indicating the
presence of GLUT4 mRNA and its protein, in normal
and PCOS tissue [5,25,26]. Therefore, to better under-
stand insulin activity in this tissue, in the present inves-
tigation proteins that participate in the pathway were
evaluated, specifically PI3K/PDK-1 pathway molecules
that are known to have a crucial role in glucose uptake
Table 3 Inmunohistochemical detection of Munc18c, PKCζ, phospho-PKCζ and Syntaxin-4, in samples from NPE and
PCOSE-IR
EPITHELIAL COMPARTMENT (IOD) STROMAL COMPARTMENT (IOD)
NPE PCOSE-IR NPE PCOSE-IR
Munc18c 1996 ± 503.9 3347 ± 656.8 1497 ± 336.1 3380 ± 819
‡
PKC ζ 8137 ± 2285 4652 ± 810.6
‡ 2646 ± 928.8* 2745 ± 665
Phospho-PKC ζ 4765 ± 2351 276,4 ± 34.5 3274 ± 1661 346,7 ± 35.5
‡
Syntaxin-4 44882 ± 11522 29900 ± 6695
‡ 12753 ± 3576* 15818 ± 3189
The samples were semiquantified by IOD. Values are expressed as mean ± SEM. NPE = Normal Proliferative Endometrium; PCOSE-IR = women with Polycystic
Ovary Syndrome with Insulin Resistance.*p < 0.05; Epithelium Compartment vs Stromal Compartment;‡ p < 0.05; NPE v/s PCOSE-IR.
Abbreviations: AR Androgen Receptor, SHBG Sex hormone-binding globulin; FAI Free Androgen Index; HOMA IR Homeostasis Model Assessment Insulin resistance
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Page 6 of 11Figure 2 Western blot analysis in endometria from proliferative phase (NPE) and from PCOS women with insulin resistance (PCOSE-IR).
Equal amounts of protein were loaded in each lane. Munc18c (66 kDa), PKCζ (68 kDa), phospho-PKCζ (~68 kDa) and Syntaxin-4 (34 kDa) band
intensities were quantified by scanning densitometry and normalized to intensities observed for b-actin as an internal control. A representative
Western Blot for Munc18c, PKCζ, phospho-PKCζ and Syntaxin-4 is shown. The results are expressed as relative units (RU), and the values shown
are mean ± SEM in Munc18c (n = 6), PKCζ (n = 6), phospho-PKCζ (n = 6) and Syntaxin-4 (n = 6). * p < 0.05 between Munc18c (NPE v/s PCOSE-
IR) and phospho-PKCζ (NPE v/s PCOSE-IR).
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determine the presence and cellular distribution of some
key proteins involved in the translocation of GLUT4 to
the plasma membrane, in both normal and PCOS endo-
metria. The study of these molecules in the endome-
trium is of special importance because glucose serves as
the main energy provider, and inadequate uptake into
endometrial PCOS-IR cells has been often linked with
failure to conceive. In this respect, one of the proteins
assayed in the present investigation was PKCζ.P r e v i o u s
reports have shown that PKCζ participates in the remo-
delling of cortical actin [7], and the phosphorylation of
various proteins in the insulin cascade [11]. It is impor-
tant to note that phosphorylated PKCζ is lower in
PCOS-IR endometria (Figure 2), suggesting a potential
decreased translocation of activated PKCζ to the plasma
membrane and thus probably a decreased glucose
uptake in PCOS-IR endometrium [27]. It is interesting
that the remodelling of cortical actin for GLUT4 vesicle
translocation is also orchestrated by WAVE family pro-
teins. In fact, a previous study has shown reduced pro-
tein levels of N-WASP and WASP in endometrial tissue
of women with PCOS and hyperinsulinemia [24].
On the other hand, the diminished Munc18c expres-
sion in PCOS-IR endometria, as assessed by western
blot (Figure 2), could indic a t eap o s s i b l ef a i l u r ei nt h e
interaction of this protein with phosphorylated PKCζ
[9,10,28,29]. It should be mentioned that the immuno-
detection of Munc18c was higher in the stromal com-
partment on PCOS-IR endometria, we have no clear
explanation for this result, but we can speculate that
this discrepancy could reside in the different techniques
used. Interestingly, protein levels of Syntaxin-4 were not
affected by the PCOS-IR condition. Together, these data
c o u l di n d i c a t et h a tt h el o w e r e de x p r e s s i o no fM u n c 1 8 c
and phosphorylated PKCζ are not directly affecting Syn-
taxin-4 levels, suggesting there could be other proteins
responsible for the failed translocation of GLUT4 to the
plasma membrane.
The results discussed up to this point, do not allow us
to conclude if the condition of hyperandrogenism and/or
hyperinsulinemia present in the PCOS-IR condition can
affect protein levels in endometrial tissues. Therefore, in
order to better understand the action of high doses of
androgens and/or insulin, we employed an endometrial
stromal cell line which we stimulated in vitro with exo-
genous hormones. The action of testosterone and insulin
were through their specific receptors present in the
T-HESC cells. The androgen receptor is located in the
cytoplasm and nucleus of HESCs cells, whereas, the insu-
lin receptor is observed on the cell surface (unpublished
data). Therefore, we believe that testosterone and insulin
could be acting through their specific receptors present
in the cells and thus T-HESC cultures should respond to
hyperandrogenic and hyperinsulinic environments.
Our results showed that high concentrations of insulin
significantly affect the protein expression of Munc18c.
This transient hyperinsulinic condition allows us to infer
that the insulin resistant condition present in PCOS
patients could be altering the expression of this protein
without affecting the protein expression of Syntaxin-4, a
protein regulated by Munc18c. On the other hand, the
treatment with high concentrations of testosterone to the
T-HESC cells decreased the levels of both phospho-PKCζ
(Thr410) and Munc18c, suggesting that high levels of the
hormone can participate in insulin resistance in the
endometrium, which could result in disturbed glucose
uptake [1].
When T-HESC cells were stimulated with both hor-
mones, insulin and testosterone, we observed decreased
Figure 3 Immunocytochemical detection of AR in T-HESCs cells.
Rivero et al. Reproductive Biology and Endocrinology 2012, 10:17
http://www.rbej.com/content/10/1/17
Page 8 of 11Figure 4 The effects of insulin and/or testosterone on protein expression in T-HESCs cell cultures. Protein levels were assessed in cell
exposed to 100 nM insulin (HI), 100 nM testosterone (HA), 100 nM insulin plus 100 nM testosterone (HI + HA), aand control cells. Representative
Western Blot is shown below the bar graphs. Equal amounts of cell lysate were loaded in each lane, all the proteins were detected according to
molecular mass: Munc18c (66 kDa) (A), PKCζ (68 kDa) (B), phospho-PKCζ (~68 kDa) (C) and Syntaxin-4 (34 kDa) (D). Band intensities were
quantified by scanning densitometry and normalized to intensities observed for b-Actin. Results were expressed as relative units (RU), and the
values are shown as mean ± SEM, * p < 0.05 between control and each hormonal treatment.
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results are in agreement with the results obtained in this
investigation in PCOS-IR endometria for the same pro-
teins. Therefore, hormone excesses characteristic of
PCOS affect the expression of key proteins involved in
insulin action at endometrial level. This observation sug-
gests a lowered GLUT4 vesicle translocation to the cell
periphery, eventually leading to a deficient entrance of
glucose to the cell. Therefore, the defects in the insulin
signaling pathway observed at the protein level, includ-
ing Munc18c, PKCζ, phospho-PKCζ,a n dS y n t a x i n - 4i n
PCOS patients with insulin resistance, could lead to
impaired glucose uptake. Accordingly, the involvement
of insulin resistance and high androgen levels in the
molecular defects of the insulin cascade cannot be
discarded.
Conclusions
The condition of hyperinsulinism and hyperandrogenism
present in PCOS-IR patients could modulate the expres-
sion and/or the phosphorylation of proteins associated
with the insulin pathway at endometrial level. This coin-
cides with results obtained in T-HESCs cells, where
insulin and testosterone exert an effect on both the
expression and phosphorylation of associated proteins.
In summary, hormonal imbalances in PCOS-IR patients
seem to regulate protein expression, as seen in results
obtained from both Western Blot and immunohisto-
chemistry, where PCOS-IR patients seem to have low-
ered protein levels, all of which could potentially affect
the reproduction capacity of these women.
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